1839-17-4

Basic information

• Product Name: 4-N-METHYLPYRIDINE-3,4-DIAMINE
• Synonyms: 4-N-METHYLPYRIDINE-3,4-DIAMINE;N4-METHYL-PYRIDINE-3,4-DIAMINE;N4-Methyl-3,4-pyridinediamine;3-Amino-4-(methylamino)pyridine;4-(Methylamino)-3-aminopyridine;4-(Methylamino)-3-pyridineamine
• CAS NO: 1839-17-4
• Molecular Formula: C₆H₉N₃
• Molecular Weight: 123.16
• Mol File: 1839-17-4.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 317℃
• Flash Point: 146℃
• Appearance: /
• Density: 1.179
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 4-N-METHYLPYRIDINE-3,4-DIAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-N-METHYLPYRIDINE-3,4-DIAMINE(1839-17-4)
• EPA Substance Registry System: 4-N-METHYLPYRIDINE-3,4-DIAMINE(1839-17-4)

Safety Data

• Hazardous Substances Data: 1839-17-4(Hazardous Substances Data)

Usage

General Description

4-N-Methylpyridine-3,4-diamine, also known as 4-N-methyl-3,4-diaminopyridine, is a chemical compound derived from the pyridine ring. It is commonly used as a precursor in the synthesis of pharmaceuticals, agrochemicals, and materials in the chemical industry. 4-N-METHYLPYRIDINE-3,4-DIAMINE is known for its potential as a corrosion inhibitor, anti-microbial agent, and as a reactant in organic reactions. It is also used in the production of dyes, pigments, and polymers. Additionally, 4-N-methylpyridine-3,4-diamine has applications in the field of medicine, particularly in the treatment of neurological disorders and as an ingredient in hair dyes. As a versatile chemical, it is important to handle and use 4-N-methylpyridine-3,4-diamine with care due to its potential health and environmental risks.

Upstream product

• 1633-41-6 3-nitro-4-methylaminopyridine 
• 31872-62-5 4-methoxy-3-nitro-pyridine 
• 13091-23-1 4-chloro-3-nitropyridine 

Downstream Products

• 145254-30-4 N-(4-methylamino-3-pyridyl)-N'-cyclohexylthiourea 
• 35251-84-4 1,4-dihydro-pyrido[3,4-b]pyrazine-2,3-dione 
• 7397-68-4 1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one 
• 40423-52-7 1-methyl-1,3-dihydro-2H-imidazo<4,5-c>pyridin-2-one 
• 5028-32-0 1-methylimidazo<4,5-c>pyridine 
• 87359-59-9 1-N-methyl-2-(2,4-dimethoxyphenyl)imidazo<4,5-c>pyridine 
• 80675-87-2 Dimethyl-[4-(1-methyl-1H-imidazo[4,5-c]pyridin-2-yl)-phenyl]-amine 
• 80675-91-8 2-(3,4-Dimethoxy-phenyl)-1-methyl-1H-imidazo[4,5-c]pyridine 
• 80675-89-4 2-Methoxy-4-(1-methyl-1H-imidazo[4,5-c]pyridin-2-yl)-phenol 
• 80675-88-3 2-Methoxy-6-(1-methyl-1H-imidazo[4,5-c]pyridin-2-yl)-phenol 
• 143361-85-7 4-(1-Methyl-1H-imidazo[4,5-c]pyridin-2-yl)-phenylamine 
• 89734-93-0 2-phenyl-1-methylimidazo<4,5-c>pyridine 
• 45880-13-5 1,2-dimethylimidazo<4,5-c>pyridine 
• 87359-60-2 2-(2,4-dimethoxyphenyl)-1-methylimidazo<4,5-c>pyridine dihydrochloride 

Relevant articles and documents

ANTI-FIBROTIC PYRIDINONES

This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.

DRUG COMBINATIONS CONTAINING PDE4 INHIBITORS AND NSAIDS

The present invention relates to new drug combinations which contain in addition to one or more PDE4-inhibitors at least one NSAID (=non-steroidal anti-inflammatory drug) (2), processes for preparing them and their use in treating in particular respiratory complaints such as for example COPD, chronic sinusitis and asthma. The invention particularly relates to those drug combinations which contain, in addition to one or more, preferably one PDE4 inhibitor of general formula 1 wherein X is SO or SO2, but preferably SO, and wherein R1, R2, R3 and R4 have the meanings given in claim 1, at least one NSAID (2), the preparation thereof and the use thereof for the treatment of respiratory complaints.

SUBSTITUTED PIPERAZINO-DIHYDROTHIENOPYRIMIDINES

The invention relates to new piperidino-dihydrothienopyrimidines of formula 1, as well as pharmacologically acceptable salts thereof, wherein X is SO or SO2, but preferably SO, and wherein R1, R2, R3 and R4 may have the meanings given in claim 1, as well as pharmaceutical compositions which contain these compounds. These new piperidino-dihydrothienopyrimidines are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers.